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Females have generally more robust immune responses than
males for reasons that are not well-understood. Here we used
a systems analysis to investigate these differences by analyzing
the neutralizing antibody response to a trivalent inactivated
seasonal influenza vaccine (TIV) and a large number of immune
system components, including serum cytokines and chemokines,
blood cell subset frequencies, genome-wide gene expression, and
cellular responses to diverse in vitro stimuli, in 53 females and 34
males of different ages. We found elevated antibody responses to
TIV and expression of inflammatory cytokines in the serum of
females compared with males regardless of age. This inflamma-
tory profile correlated with the levels of phosphorylated STAT3
proteins in monocytes but not with the serological response to the
vaccine. In contrast, using a machine learning approach, we
identified a cluster of genes involved in lipid biosynthesis and
previously shown to be up-regulated by testosterone that corre-
lated with poor virus-neutralizing activity in men. Moreover, men
with elevated serum testosterone levels and associated gene
signatures exhibited the lowest antibody responses to TIV. These
results demonstrate a strong association between androgens and
genes involved in lipid metabolism, suggesting that these could be
important drivers of the differences in immune responses between
males and females.
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The variability in the biology of human populations poses sig-nificant challenges in understanding different disease out-
comes and developing successful therapeutics. The sources of this
variation are likely the consequence of genetics, epigenetics, and
the history of antigenic exposure (1, 2). As therapies targeting
immune function are developed to improve clinical outcomes in
cancer, viral and bacterial infections, autoimmune diseases, and
transplantation, identifying the sources of immunological varia-
tion and finding biomarkers for immune health and dysfunction
are crucial for their success (3).
An important source of immunological variation is known to be
the sex of the individual. Males experience a greater severity and
prevalence of bacterial, viral, fungal, and parasitic infections than
females, who also exhibit a more robust response to antigenic
challenges such as infection and vaccination (4, 5). This stronger
immune response in females could also explain why they more
frequently develop immune-mediated pathologies during influenza
infection, such as an overproduction of cytokines (cytokine storm)
that contribute to an increase in capillary permeability and lung
failure (6). Furthermore, females are at a higher risk for de-
veloping autoimmune diseases. In this later context, it is interesting
to note that a recent study showed that females had, on average,
1.7 times the frequency of self-specific T cells as males (7). Despite
the fact that initial observations relating the sex of the individual
with the immune response were made many years ago (8), little is
known about the mechanisms underlying these differences.
Some sex-specific variations in the immune response can be di-
rectly attributed to sex hormones (9). In humans, sex steroids can
bind to intracellular receptors located in immune cells such as
monocytes, B cells, and T cells and activate hormone-responsive
genes, suggesting that they can directly affect sex-related differ-
ences in both innate and adaptive immune responses (10).Whereas
estrogens are associated with inflammation and can stimulate
proliferation and differentiation of lymphocytes and monocytes,
androgens suppress the activity of immune cells by increasing the
synthesis of anti-inflammatory cytokines (11, 12).
To date, no clear associations have been found between bi-
ological and clinical differences in the immune response between
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males and females in humans. In one study, results from public
gene expression data (13) showed that many of the genes in-
duced by a yellow fever vaccine were preferentially activated in
females (14). However, whether these differences correlate with
poor antibody outcomes remains to be determined.
In this study, we sought to determine whether we could identify
biomarkers from peripheral blood that could explain the sex-related
differences in the serological response to the trivalent inactivated
seasonal influenza vaccine (TIV) in both young and older cohorts.
Young and older females had higher neutralizing antibodies
than age-matched males, consistent with previous reports (15).
Females also showed higher expression of inflammatory mark-
ers. However, none of these specific sex-related differences
correlated with the observed disparities in the antibody response
to TIV. Nevertheless, using a machine learning approach, we
identified a set of genes previously shown to be regulated by
testosterone and participating in lipid biosynthesis, whose ex-
pression was negatively associated with antibody responses to
TIV in the male subjects in our study. Moreover, males with high
levels of serum testosterone and expressing related gene sig-
natures in blood cells showed the lowest neutralizing responses
to TIV. These results suggest that testosterone might be immu-
nosuppressive in vivo in humans, and indicate that its effect on
an influenza vaccine and other immune responses could be due
to the regulation of genes implicated in the metabolism of lipids.
Results
Elevated Levels of Neutralizing Antibodies upon Influenza Vaccination
and Inflammatory Markers in Serum from Females Versus Males. To
study the differences in males’ versus females’ immune systems,
we used data from a vaccination and systems immunology study
conducted on 91 individuals (37 males and 54 females) of dif-
ferent ages (20–30 and 60–>89 y old) (Table 1) that we recently
reported (16). We studied a variety of immune parameters from
peripheral blood before vaccination, including cytokines, che-
mokines, and growth factors in serum, frequencies of diverse
blood cell subsets, phosphorylation levels of signal transducer
and activator of transcription (STAT) proteins in multiple cells
stimulated with a variety of cytokines or unstimulated (96 con-
ditions in total), and whole-blood gene expression. The gene
expression data were reduced to 109 gene modules by cluster
analysis and assignment of a set of transcription factors (regu-
latory program) to each gene module as described (16) (SI
Materials and Methods). Four individuals were removed from the
analysis: two outliers and two with incomplete datasets.
To determine the magnitude of the antibody response to
TIV, we performed virus microneutralization assays. The se-
roconversion rate (percent of individuals with a fourfold or
greater change in their post- versus prevaccination micro-
neutralization titer) was computed for each group and strain
in the vaccine (SI Materials and Methods). We conducted lo-
gistic regression analysis on each of the titer changes (corre-
sponding to the H1N1, H3N2, and B strains) and included the
age and sex variables in the model, because age was expected
to modify vaccine responses. Females had a greater response
than males to the H3N2 strain (P = 0.0027) and to a lesser
extent to the B strain (P = 0.02). In contrast, despite a strong
age effect (P = 0.0035), no differences according to sex were
found for the H1N1 strain (Table 2).
To determine the differences in the baseline’s immune measures
in males versus females, we conducted differential expression
analysis across a total of 278 parameters using significance analysis
of microarrays (SAM) (17) and found significant differences in 7
parameters [false discovery rate (FDR) Q < 0.1], 6 of which were
increased in females (Fig. 1). Strikingly, these included several
known markers of inflammation, such as LEPTIN, interleukin
(IL)-1 receptor agonist (RA), C-reactive protein (CRP), Gran-
ulocyte macrophage-colony stimulating factor (GM-CSF), and
Interleukin IL-5, as well as the phosphorylation levels of
STAT3 proteins in unstimulated monocytes (M-pSTAT3).
One parameter (gene module 106) was up-regulated in
males compared with females. A significant fraction of this gene
module is composed of genes located on the Y chromosome
(enrichment P < 10−9) (Table S1). Interestingly, genes partici-
pating in the activation of v-akt murine thymoma viral oncogene
homolog (Akt) and phospholipase C (PLC) proteins such as
mature T-cell proliferation 1 (MTCP1) and phosphatidylinositol-
specific phospholipase C, X domain containing 1 (PLCXD1),
respectively, clustered with Y chromosome-linked genes in
module 106. The regulatory program derived for module 106
(Fig. S1) included genes previously shown to be differentially
regulated in males versus females, such as CLOCK (18), ENY2
(19), and IRF1 and IRF7 (20).
It has long been noted that inflammatory markers, especially
IL-6, TNF-α, and IL-1β, among others, are increased in the el-
derly. Thus, we divided the individuals by age group (young, 20–
30 y old; old, 60–>89 y old) and investigated whether these
differences were also observed in our aging cohort. The serum
levels of LEPTIN, IL1-RA, CRP, GM-CSF, and IL-5 were all
higher in females regardless of age group (P < 0.05) (Fig. 2).
However, the differences for CRP, IL1-RA, and LEPTIN were
less pronounced in the older group due to an overall increase in
the levels of these proteins in older compared with younger
males (P = 0.007, by Fisher’s combined probability). Strikingly,
M-pSTAT3 levels were significantly higher in females among
young subjects (P = 0.002) but not in the elderly (P = 0.268),
where both sexes had similar levels to those found in young
females (Fig. 2). This suggested that other cytokines that signal
through STAT3 (e.g., IL-6, IL-11, and LIF, among others) were
elevated in both males and females in the older cohort. Because
IL-6 is one of the hallmark cytokines of aging, we directly
compared IL-6 levels in young versus older (without correction
for multiple comparisons) and noticed elevated levels in elderly
subjects (Fig. S2), consistent with multiple previous reports.
To identify associations between these sex-related features, we
generated correlation matrices and conducted unsupervised
clustering with or without IL-6. Interestingly, M-pSTAT3 clus-
tered with CRP and GM-CSF (Fig. S3A), or with CRP, IL-6, and
GM-CSF when IL-6 was incorporated in the clustering analysis
(Fig. S3B), suggesting that the intracellular levels of phosphorylated
Table 1. Subjects’ baseline characteristics
Males Females P value
Number of subjects 37 54 —
Age range (median), y 20–>89 (63) 20–>89 (68) 0.14
BMI range (median) 19–36 (25) 18–47 (24) 0.61
Cytomegalovirus (+), % 61 57 0.73
Epstein–Barr virus (+), % 70 54 0.13
BMI, body mass index.
Table 2. Age and sex effects on microneutralization antibody
titer responses to influenza vaccination
Beta SE z value P value
H1N1 (Intercept) −0.272 0.229 −1.190 0.234
Age −0.690 0.236 −2.919 0.004
Sex −0.011 0.234 −0.047 0.962
H3N2 (Intercept) −0.038 0.228 −0.166 0.868
Age −0.190 0.236 −0.804 0.421
Sex −0.716 0.239 −2.992 0.003
B (Intercept) −0.502 0.236 −2.128 0.033
Age −0.583 0.246 −2.367 0.018
Sex −0.594 0.256 −2.324 0.020
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STAT proteins in monocytes likely represent a functional readout
corresponding to an inflammatory environment in vivo.
These results indicate that females have a stronger neutralizing
response to influenza vaccination and an increased inflammatory
serum profile, which correlates with the baseline levels of phos-
phorylated STAT3 proteins in peripheral monocytes.
Weaker Vaccine Responses in Males with High Expression of Genes
Involved in Lipid Metabolism. To identify features associated with
the observed sex differences in vaccine responsiveness, we fo-
cused on the neutralizing activity to H3N2 because the largest
differences between males and females were found for this
strain. Also, this influenza strain is important in a public health
context because it causes the highest rates of morbidity and
mortality during the influenza season (21). An individual was
considered a responder if they had the standard fourfold or
greater change in their post- versus prevaccination micro-
neutralization titer (seroconversion). For H3N2, 33 females and
10 males were responders and 20 females and 24 males were
nonresponders. We first searched for possible confounding fac-
tors by investigating which features could substantially modify
the observed sex effect. In brief, we performed forward stepwise
logistic regression with sex as the initial predictor. In stepwise
regression, each of the immune features was incorporated into
the model iteratively and statistics were computed to account for
modifications in the regression coefficient of sex (SI Materials
and Methods). The iterations were stopped when the added
feature did not modify the regression coefficient of sex to the
standard threshold 20%. By this procedure, we identified two
possible confounders: a gene module enriched for genes encoding
for ribosomal proteins (module 042) (enrichment P < 10−6) and
the acute-phase inflammatory marker CRP. Thus, we generated
a first model (model 1), which included the variables of sex,
module 042, and CRP. The resulting regression coefficient for sex
in model 1, after adjusting for confounders, was −2.03 compared
with −1.38 (sex variable alone) (Fig. S4).
We then searched for gene expression profiles that could ex-
plain the differences in vaccine responsiveness between males and
females, namely features having different effects in males or
females, while adjusting for confounding variables. To do so, we
used the Interact package (SI Materials and Methods), which
searches for significant interactions between predictors using
permutation methods. A significant interaction (FDR Q < 0.1)
was identified for a module enriched for genes participating in
lipid biosynthesis (enrichment P < 0.001) (module 052) (Table
S1). These genes included LTA4H, encoding for leukotriene A4
hydrolase, which converts leukotriene A4 (LTA4) to active LTB4;
MIF (macrophage migration inhibitory factor), which plays a role
in the anti-inflammatory effects of glucocorticoids (22); PDSS2
(decaprenyl-diphosphate synthase subunit 2), whose product syn-
thesizes the prenyl side chain of coenzyme Q; and PEX5 (perox-
isomal biogenesis factor 5), involved in fatty acid metabolism. The
gene regulators derived for module 052 (Fig. S1B) included
CLOCK (activator) and FBJ murine osteosarcoma viral oncogene
homolog (FOS), Jun B proto-oncogene (JUNB), and Jun D proto-
oncogene (JUND) (repressors), among others. Interestingly, the
CLOCK gene is involved in the regulation of circadian rhythms, as
well as in lipid metabolism (23).
We then generated a second model (model 2), which included
the variables of sex and module 052, the interaction term (sex ×
module 052), and the covariates CRP and module 042. The
resulting odds ratio (OR) estimate for vaccine response based on
the expression of module 052 in model 2 was 0.39 [confidence
interval (CI), 0.18–0.84] for males and 2.25 (CI, 1.08–4.67) for
females (Fig. 3A). This indicates that the probability of being
a high responder to TIV decreases significantly with an elevated
expression of module 052 in males and with decreased expres-
sion of module 052 in females. To determine the extent to which

















































































































Fig. 1. Significant differences in baseline immune parameters between
females and males. Expression of a total of 278 immune features and gene
modules was compared between females (F) (n = 53) and males (M) (n = 34)
of different age groups, including serum cytokines, chemokines, and growth
factors; frequencies of over 15 blood cell subsets; phosphorylation events in
multiple immune cells; and whole-genome gene expression using SAM. A
cutoff of Q < 0.1 and absolute score(d) > 2 was considered significant (vol-
cano plot; Top, Left). Inflammatory markers including LEPTIN, IL-1RA, and
CRP and other serum proteins were elevated in females compared with
males. mono.Unstimulated.STAT3, baseline levels of pSTAT3 in isolated
monocytes. A single gene module (module 106) (Bottom, Right) was dif-
ferentially expressed (and up-regulated in males). Module 106 is enriched for
genes located on the Y chromosome (P < 10−9). Lower whisker represents the
minimum value, lower hinge the first quartile, upper hinge the third quartile,
and upper whisker the maximum value. Outliers are represented by circles.










classification model, we computed a cross-validated area under
the curve (cvAUC) for model 1 and model 2. The cvAUC was
0.712 for model 1, and 0.761 for model 2. Furthermore, direct
comparison of the two models shows that model 1 is significantly
better than model 2 (P = 0.0019, by likelihood ratio test).
These results suggest that the observed sex differences in the
neutralizing antibody responses to vaccination could be medi-
ated by the expression of genes involved in lipid metabolism.
Blunted Vaccine Response in Males with High Levels of Testosterone
and Elevated Expression of Genes Involved in Lipid Metabolism. Our
results showing that augmented expression of module 052 cor-
related with weaker vaccine responsiveness in males but not in
females suggested that sex hormones could be involved in ex-
pression of this gene module. Indeed, results from chemical–
gene interaction analysis (http://ctdbase.org) (24) show that ex-
pression of a significant fraction of genes in module 052 can be
modulated by testosterone (P < 0.005, by hypergeometric test).
Thus, we measured free (unbound, bioactive form) testosterone
in the sera from the individuals in our study with the hypothesis
that, in males, the observed effect of module 052 on vaccine
response was dependent on the circulating levels of testosterone.
We stratified the male subjects into testosterone high (Thi) or
low (Tlo), if they were above or below the median for all of the
male subjects (4.06 pg/mL; range, 0.58–24.78 pg/mL), and gen-
erated a third model (model 3) for vaccine-neutralizing response,
in which male subjects were replaced by Thi (n = 17) and Tlo
(n = 17). The median testosterone level in Thi subjects was 9.55
pg/mL (range, 4.25–24.78 pg/mL), and 2.34 pg/mL (range, 0.58–
3.89 pg/mL) in Tlo subjects. The median age for Tlo and Thi
males was 77 and 24 y, respectively. Thus, model 3 included the
interaction terms module 052 × Thi and module 052 × Tlo, and
was also adjusted for age, because of the effect of aging on
testosterone levels. Strikingly, the interaction between testos-
terone levels and module 052 was significant only for the Thi
group (P < 0.005) and not for Tlo males (P = 0.18), and the
corresponding OR estimates for vaccine response, according to
module 052, were 0.87 (CI, 0.28–2.69) for Tlo and 0.19 (CI,
0.04–0.80) for Thi males. We also tested testosterone levels as
a continuous measure by replacing the interaction terms module
052 × Thi and module 052 × Tlo with module 052 × testoster-
one; the model was also adjusted by sex and age. Consistent with
model 3, the interaction of module 052 and testosterone levels
was significant (P = 0.012) (Fig. S5). This indicates that module
052 has a significant effect on vaccine response in males with
high levels of testosterone but not in those with lower levels.
Together, these results show that in males with higher levels of
testosterone and elevated expression of genes that participate in
lipid metabolism, the antibody response to vaccination is severely
down-regulated, whereas in those with low levels of testosterone,
or in females, the contribution of module 052 is not detrimental
and the responses to the vaccine remain intact.
Discussion
In this study, we have used a systems approach to the analysis of
sex differences in the immune system in humans. These data re-
inforce and extend previous reports, and point toward a mecha-
nistic hypothesis that may drive the sex disparities observed in
responses to vaccination. Differences in vaccine responsiveness
in males versus females have been reported for most commercially
available vaccines including yellow fever, influenza, measles, mumps,
rubella, and hepatitis, among others (5). As in these studies, we find
stronger responses to influenza vaccination and significantly in-
creased serum levels of proinflammatory molecules in females
compared with males, specifically LEPTIN (25), IL-RA (26), and
CRP (27). In addition, we find differences in GM-CSF and IL-5
and in the baseline pSTAT3 levels in monocytes, which correlate
with serum CRP, IL-6, and GM-CSF. Consistent with this,
LEPTIN and IL-6 activate STAT3 in monocytes, which results in
the secretion of CRP and IL1-RA (28, 29). We also find that these
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Fig. 2. Differences in baseline immune parame-
ters between females and males by age group.
The individuals were first divided by age group
(58 older and 29 young), and the significant dif-
ferences identified between all females (yellow
bars) and males (blue bars) using SAM (seven in
total; Fig. 1) were used to investigate differences
in expression by age group. With the exception of
mono.Unstimulated.STAT3, all significant differences
between all males and females identified previously
were also observed in both age groups (P < 0.05).
However, the differences in LEPTIN, IL-1RA, and CRP
were less pronounced in older individuals due to an
overall increase in the levels of these proteins in the
serum of older males compared with young males
(P < 0.05). F, females; M, males. mono.Unstimulated.
STAT3, baseline levels of pSTAT3 in isolated mon-
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Fig. 3. Odds ratio for vaccine responses in males and females based on
expression of module 052. Interaction analysis was conducted for sex and
gene expression modules on the serological (microneutralization) responses
to TIV (seroconversion to the H3N2 strain). A significant interaction was
found between the variables sex and gene module 052. (A) Odds ratio for
vaccine response given module 052 in females (red line) and males (blue
line). (B) No significant interaction between sex and module 052 is ob-
served for males with low levels of testosterone [Tlo (n = 17), brown line],
although a significantly negative effect of module 052 is observed for
males with high levels of testosterone [Thi (n = 17), blue line] (adjusted for
confounders including age).
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subjects, possibly due to increased levels of other cytokines
signaling through STAT3 in both sexes from the older cohort (e.g.,
IL-6). Therefore, the level of pSTAT3 in monocytes likely reflects
the sum of diverse inflammatory stimuli targeting STAT3. Con-
sistent with these observations, the phosphorylation levels of
STAT3 and other STAT proteins have been found to be increased
in asthma (30) and in other inflammatory conditions (31).
With respect to the influenza vaccine response, our results
indicate that the natural variation in circulating free testosterone
could drive many of the differences observed in the response to
vaccines. In particular, males with elevated levels of serum tes-
tosterone and high expression of genes participating in lipid
metabolism were significantly less likely to respond to TIV.
These results are in agreement with previous findings showing an
immunosuppressive role of testosterone in animals and in vitro
(11, 32) with an increase in the synthesis of anti-inflammatory
cytokines such as IL-10 (12). Consistently, men with androgen
deficiencies have higher levels of inflammatory cytokines than
healthy controls (33). However, we did not find an association
between the proinflammatory cytokines that are differentially
expressed in females and males and the response to vaccination.
Rather, our data indicate that other molecules, such as those
involved in lipid biosynthesis, are likely affected by testosterone
and modulate the antibody response. In particular, our results
suggest that testosterone could act by decreasing expression of
transcription factors such as FOS, JUNB, and JUND that, in turn,
repress the expression of gene module 052 (Fig. S1B). Consistent
with this hypothesis, androgen receptor signaling antagonizes NF-
κB and represses AP-1 (FOS/JUN), which mediates the pro-
duction of proinflammatory and antiviral cytokines (34, 35).
A particularly interesting gene found in module 052 is LTA4H,
one of the members of the epoxide hydrolase family. The product
of this gene catalyzes the conversion of LTA4 (originating from
arachidonic acid) to LTB4, a lipid mediator that has both proin-
flammatory (via surface receptors) and anti-inflammatory (via
activation of peroxisome proliferator-activated receptors and de-
creased NF-κB expression) activities. Furthermore, LTB4 seems
to participate in the differentiation of suppressor cells both from
the myeloid (36) as well as from the lymphoid (37) compartments.
More generally, several studies in both humans and mice have
shown the ability of LTB4 precursors, such as omega-3 and -6
fatty acids, to suppress inflammatory responses (38, 39).
Other potentially relevant genes in module 052 are MIF,
PDSS2, and PEX5. MIF participates in the synthesis of prosta-
glandin E2, a lipid compound that originates from arachidonic
acid, binds to immune cells (T cells and dendritic cells), and
suppresses inflammatory cytokine production (40, 41). A less
clear association is observed for PDSS2, an enzyme that medi-
ates isoprenoid biosynthesis and the incorporation of lipids in
proteins. Last, PEX5 participates in the biogenesis of perox-
isomes, which regulate various metabolic activities including the
degradation of very long chain fatty acids. Peroxisomes have also
been implicated in the innate immune system, with a significant
reduction observed in inflammation, apparently related to the
suppressive effect of TNF-α on peroxisome function (42).
Recent studies have also focused on the possibility that genes
located on the X and Y chromosomes also affect the response to
vaccination. Polymorphisms in genes on the X chromosome that
encode for immunological proteins can influence immune
responses to vaccines. For example, Toll-like receptor 7, located
on the X chromosome, can escape X inactivation, resulting in
higher expression in females than in males (43). Y chromosome
genes have also been shown to affect sex-dependent suscepti-
bility to autoimmune disease and possibly to other immune
functions (44). However, our results indicate that the expression
of genes on the Y chromosome might not be involved in the
immune response to vaccines, because the sex-related gene
module 106 was not associated with the differences in the re-
sponse to TIV despite the observation that genes regulating
important immune functions such as the activation of Akt and
PLC proteins by MTCP1 and PLCXD1, respectively, are clus-
tered together with Y chromosome genes in this module.
In conclusion, our results are consistent with a large body of work
in animals showing that testosterone is immunosuppressive in vivo
and extend this to humans responding to a seasonal influenza
vaccine and exhibiting typical variations in testosterone levels. We
suggest that testosterone acts directly on immune cells by repressing
transcription factors (such as FOS, JUN, and others) implicated in
immune activation; these transcription factors would in turn repress
the expression of genes involved in lipid metabolism with immu-
nosuppressive activities, creating a negative feedback loop.
From an evolutionary perspective, the immunosuppressive effects
of testosterone could be advantageous as a possible homeostatic
mechanism to turn off the immune response. For instance, experi-
ments with highly pathogenic viruses reconstructed from isolates
from the 1918 influenza pandemic (which killed over 50 million
people) show that infection with this strain in animal models results
in an uncontrolled, deadly cytokine storm (45). Furthermore, sup-
pression of this inflammatory response in infected mice ameliorates
immunopathology and decreases mortality (6, 46). It has also been
noted that testosterone treatment of castrated male mice made
them less susceptible to LPS-induced shock (32). Because males of
many species are more likely to experience trauma than females,
this positive effect of testosterone may also help to balance out the
consequences of reduced immunity to infection.
In summary, we have identified unique proinflammatory markers
that are differentially expressed in females compared with males, as
well as genes that participate in lipid metabolism that could be
modulated by the levels of free testosterone in normal pop-
ulations and correlate with the sex-related bias in the re-
sponsiveness to influenza vaccination.
Materials and Methods
Subjects, Specimens, and Vaccination Protocol. With the exception of the
neutralizing antibody response to the vaccine and the determination of
testosterone measurements from serum, this study used baseline-level data
from a previously published work conducted in 91 healthy donors who were
enrolled in an influenza vaccine study at the Stanford-Lucile Packard
Children’s Hospital (LPCH) Vaccine Program during the 2008–2009 influenza
season (16). Thus, only a brief description of the methods is included here.
The protocol of the study was approved by the Institutional Review Board of
the Research Compliance Office at Stanford University. Blood samples were
obtained prevaccination and 28 ± 7 d after receiving a single dose of TIV
Fluzone (Sanofi Pasteur). Whole blood was used for gene expression analysis
as described (16). Peripheral blood mononuclear cells (PBMCs) were obtained
by density gradient centrifugation (Ficoll-Paque) and frozen at −80 °C before
transferring to liquid nitrogen. Serum was separated by centrifugation of
clotted blood and stored at −80 °C before use. Whole blood, PBMCs, or serum
from the first visit (baseline, day 0) was processed and used for determination
of gene expression, leukocyte subset frequency, signaling responses to stim-
ulation, serum cytokine and chemokine levels, testosterone levels, and CMV
and EBV serostatus by ELISA (Calbiotech). Serum samples from day 0 and day
∼28 were used for virus microneutralization titer determination.
Virus Microneutralization Assay. A standard plaque reduction virus micro-
neutralization assay was performed. In brief, serum samples were heat-inacti-
vated for 30 min at 56 °C, serially diluted (twofold) in virus diluent (DMEM, 1%
BSA, antibiotics, and 25 mM Hepes), and mixed with 100 median tissue culture
infective doses each of the H1N1, H3N2, and B strains (kind gift of George
Kemble, MedImmune). Plates were incubated 1 h at 37 °C and 5% CO2, and
1.5 × 104 exponentially growing Madin–Darby canine kidney-London cells
(kind gift of David Lewis, Stanford University) were added in 100 μL of virus
diluent. Cell cultures were then incubated overnight at 37 °C and 5% CO2,
and washed and fixed with ice-cold acetone for 10 min at room tempera-
ture. Fixative was discarded and plates were air-dried. After several washes
with washing buffer (PBS, 0.1% Tween-20), wells were incubated for 1 h at
room temperature with an anti-influenza A or B nucleoprotein mouse
monoclonal antibody (KPL) at 1:4,000 in blocking buffer (PBS, 1% BSA,
0.1% Tween-20). After washing, a secondary antibody (goat anti-mouse
IgG, HP-conjugated; KPL) was added at 1:2,000 in blocking buffer and










incubated 1 h at room temperature before revealing with HRP substrate.
Absorbance (OD) was read at 490 nm.
Whole-Blood Microarray Analysis of Gene Expression. The procedures for RNA
extraction, quantification, hybridization, and scanning were described pre-
viously (16). The original microarray probe-level data files can be accessed at
the Gene Expression Omnibus repository under accession number GSE41080.
Leukocyte Subset Frequency Determination. PBMCs were thawed, washed
with FACS buffer (PBS supplemented with 2% FBS and 0.1% Na azide), and
stained with three separate anti-human antibody mixtures containing (i)
anti-CD3 AmCyan, CD4 Pacific Blue, CD8 allophycocyanin (APC) H7, and
CD28 APC; (ii) CD3 AmCyan, CD4 Pacific Blue, CD8 APCH7, CD27 PE, and
CD45RA PE-Cy5; and (iii) CD3 AmCyan, CD19 Alexa Fluor 700, CD56 PE, CD33
PE-Cy7, and TCR APC, all reagents from BD Biosciences. After incubation,
cells were washed several times and data were collected using DIVA soft-
ware on an LSR II instrument (BD Biosciences) and analyzed using FlowJo
8.8.6 (Tree Star).
Phosphorylation of Intracellular Proteins by Phosphoflow. Cells were thawed
with FACS buffer and stimulatedwith the indicated cytokines for 15min inwarm
media (RPMIwith 10%FBS). Cellswerewashedand fixedwith paraformaldehyde
and permeabilized with 95% ice-cold methanol. Different stimulus conditions
were bar-coded using a 3 × 3 matrix with Pacific Orange and Alexa Fluor 750
(Invitrogen). Cell mixtures were stained with an antibody mixture as described
previously (16). Data were collected using DIVA software and analyzed with
FlowJo 8.8.6.
Serum Cytokine-Level Determination. Cytokines were measured on a Luminex
system. Fifty-plex kits were purchased from Millipore and used according to
the manufacturer’s recommendations with some modifications.
Testosterone-Level Determination. Serum levels of free testosterone were
measured using the Free Testosterone ELISA Kit (Calbiotech) as recom-
mended by the manufacturer.
Statistical Analysis. Statistical procedures for gene module construction, in-
teraction analysis, and modeling of vaccine responsiveness can be found in SI
Materials and Methods.
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